Before revision: Esketamine is a more potent NMDA receptor pore blocker than arketamine , However, preclinical data suggest that (R)‐ketamine exerts greater potency and longer‐lasting antidepressant effects than (S)‐ketamine and that (R)‐ketamine has less detrimental side‐effects than (R,S)‐ketamine or (S)‐ketamine.
After revision: Esketamine is a more potent NMDA receptor pore blocker than arketamine far